Condition: Portal Hypertension · TIPS · Sponsor: C. R. Bard
The objective of the study is to assess the safety and effectiveness of the BD Liverty™ TIPS Stent Graft for the treatment of the complications of portal hypertension from cirrhosis. This includes recurrent or refractory ascites, hepatic hydrothorax, and/or variceal bleeding (esophageal and/or gastric).
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Stanford University | Palo Alto, California, United States | — |
| Georgetown University | Washington D.C., District of Columbia, United States | — |
| Trustees of Indiana University ("IU")/ Indiana University Health, Inc. | Indianapolis, Indiana, United States | — |
| University of Kansas Medical Center Research Institute, Inc. | Kansas City, Kansas, United States | — |
| The General Hospital Corporation d/b/a Massachusetts General Hospital | Boston, Massachusetts, United States | — |
| Beth Israel Deaconess Medical Center, Inc. | Boston, Massachusetts, United States | — |
| Washington University - Mallinckrodt Institute of Radiology | St Louis, Missouri, United States | — |
| Rutgers, The State University of New Jersey | Newark, New Jersey, United States | — |
| Icahn School of Medicine at Mount Sinai | New York, New York, United States | — |
| The Trustees of Columbia University in the City of New York | New York, New York, United States | — |
| Charlotte Radiology | Charlotte, North Carolina, United States | — |
| Cleveland Clinic Foundation | Cleveland, Ohio, United States | — |
+ 14 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.